Stefan Schröder

Dr. Stefan Schröder is an Analyst at Montega AG.
He is an acknowledged expert in health care.
He has broad expertise in biotech, pharmaceuticals, and medical technology and many years of experience.
Following his doctorate in biochemistry at the University of Munich, he first worked as an assistant professor at the University of Odense (Denmark) on applications of quantitative proteomics and ESI mass spectrometry in tumor research and subsequently was doing research for the Canadian-Danish biotech company MDS Proteomics.
Attracted by the perspective of combining specialized know-how and money to trigger future-oriented investments, Stefan joined the financial industry in 2005.
As an analyst at SES Research (today: Warburg Research), he covered the life sciences sector for several years.
In this function, he significantly supported M.
M.
Warburg bank to complete many capital measures and IPO of biotech and MedTech companies and was also responsible for the evaluation of private equity investments.
He studied biochemistry at the University of Tübingen, received his degree at the Eidgenössische Technische Hochschule (Technical University) in Zurich, and earned his doctorate in a pharmacological research group with a thesis on regulating G-protein-coupled hormone receptors.
He rounded off his qualification with a second degree in business.